Screener
ClearPoint Neuro CLPT EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
Based on trailing twelve months.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
FAQ
- What is ClearPoint Neuro's EBITDA margin?
- ClearPoint Neuro (CLPT) reported EBITDA margin of -63.2% in Q1 2026.
- How has ClearPoint Neuro's EBITDA margin changed year-over-year?
- ClearPoint Neuro's EBITDA margin increased by 2.2% year-over-year, from -64.7% to -63.2%.
- What is the long-term trend for ClearPoint Neuro's EBITDA margin?
- Over 5 years (2020 to 2025), ClearPoint Neuro's EBITDA margin has grown at a 6.6% compound annual growth rate (CAGR), from -45.9% to -63.2%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about ClearPoint Neuro's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude